1 Aug 2020

Virtual work experience week engages pupils remotely

Over 40 pupils from across Scotland recently came together online to attend a virtual work experience week at the University of Dundee.  Each year the School of Life Sciences hosts S5-6 students from local schools to give pupils the opportunity to investigate potential career opportunities before moving into further education. This year, due to the coronavirus pandemic, the Life Science Work Experience Week was brought online for the first time and included the School of Medicine, introducing pupils from across the country to the world of science research and study at the University.  The program...

5 Jun 2020

National study into long-term Covid-19 impacts launched

The School of Medicine’s Professor James Chalmers is the Scottish lead of a major UK research study into the long-term health impacts of Covid-19 on hospitalised patients. The PHOSP-COVID study has been awarded £8.4 million jointly by UK Research and Innovation (UKRI) and the National Institute for Health Research (NIHR). It is one of a number of Covid-19 studies that have been given urgent public health research status by the Department of Health and Social Care. Led nationally by the NIHR Leicester Biomedical Research Centre, the PHOSP-COVID study will draw on expertise from a conso...

3 Jul 2020

Wimberley Award 2020 shared by Christoffer and Scott

The University's prestigious Wimberley Award has been given to joint winners, Scott Mackenzie and Christoffer Nielsen, who both showed outstanding academic achievement alongside a commitment to social, political and health advocacy throughout their time at the University of Dundee. The Wimberley Award is an annual honour given by the principal to students who have made a distinguished contribution to University life during their studies. Scott (23) graduated early in medicine and joined the cohort of junior doctors helping to fight the coronavirus pandemic, while Christoffer (24) graduated with a first-c...

30 Jun 2020

Re-purposed drugs could reverse blood vessel damage in diabetes

Drugs that were developed to treat Alzheimer’s Disease could be re-purposed to prevent - or even reverse - the damage done to the blood vessels in people who are obese or suffer from type 2 diabetes, according to new research. People suffering from a range of conditions called metabolic syndrome – which includes type 2 diabetes, high blood pressure, high cholesterol and obesity – have a stiffening of their blood vessels that puts them at increased risk of a heart attack or stroke. In a breakthrough, scientists at the University of Dundee and the University of Leeds have discovered a key...